Gudbjornsson Brynjar Thor, Haraldsson Ásgeir, Einarsdóttir Hildur, Thorarensen Ólafur
Faculty of Medicine, University of Iceland, Reykjavík, Iceland.
Faculty of Medicine, University of Iceland, Reykjavík, Iceland; Children's Hospital Iceland, Landspítali - University Hospital Iceland, Reykjavík, Iceland.
Pediatr Neurol. 2015 Dec;53(6):503-7. doi: 10.1016/j.pediatrneurol.2015.08.020. Epub 2015 Sep 5.
Recognizing acquired demyelinating syndromes and multiple sclerosis is important to commence early treatment. The objective of this study was to describe the incidence of acquired demyelinating syndromes and multiple sclerosis among the entire Icelandic pediatric population according to recently promoted criteria.
The study included all children in Iceland (<18 years) with acquired demyelinating syndromes and multiple sclerosis from 1990 to 2009 with a minimum of 5-year follow-up. Clinical data were gathered and radiological images reviewed. The cohort included all patients with acquired demyelinating syndromes and multiple sclerosis in the Icelandic pediatric population.
Eighteen patients with acquired demyelinating syndromes and multiple sclerosis were included, the total annual incidence being 1.15/100,000 (acquired demyelinating syndromes 1.02 and multiple sclerosis 0.45/100,000). The median age at diagnosis was 14.25 years (range 1.25-17.5 years). Thirteen patients were initially diagnosed with clinically isolated syndrome, two had acute disseminated encephalomyelitis, two had multiple sclerosis, and one had neuromyelitis optica. Seven children were diagnosed with multiple sclerosis; three patients with clinically isolated syndrome developed multiple sclerosis after the age of 18 and were not included in the multiple sclerosis group. The gender ratio was equal. Of the nine girls, seven were diagnosed with clinically isolated syndrome. Most patients (11 of 18) were diagnosed during the period January through March. Oligoclonal bands in cerebrospinal fluid were exclusively found in patients with multiple sclerosis and clinically isolated syndrome and 13 of 14 available magnetic resonance images revealed clear abnormalities.
The annual incidence of acquired demyelinating syndromes and multiple sclerosis in Iceland was 1.15/100,000 children. The risk of progression from clinically isolated syndrome to multiple sclerosis was high. There was no female preponderance.
识别获得性脱髓鞘综合征和多发性硬化症对于尽早开始治疗至关重要。本研究的目的是根据最近推广的标准描述冰岛全体儿科人群中获得性脱髓鞘综合征和多发性硬化症的发病率。
该研究纳入了1990年至2009年期间冰岛所有患有获得性脱髓鞘综合征和多发性硬化症且至少随访5年的儿童(年龄<18岁)。收集临床数据并复查放射影像。该队列包括冰岛儿科人群中所有患有获得性脱髓鞘综合征和多发性硬化症的患者。
纳入了18例患有获得性脱髓鞘综合征和多发性硬化症的患者,年总发病率为1.15/100,000(获得性脱髓鞘综合征为1.02,多发性硬化症为0.45/100,000)。诊断时的中位年龄为14.25岁(范围1.25 - 17.5岁)。13例患者最初被诊断为临床孤立综合征,2例患有急性播散性脑脊髓炎,2例患有多发性硬化症,1例患有视神经脊髓炎。7名儿童被诊断为多发性硬化症;3例临床孤立综合征患者在18岁后发展为多发性硬化症,未纳入多发性硬化症组。性别比例相等。9名女孩中,7例被诊断为临床孤立综合征。大多数患者(18例中的11例)在1月至3月期间被诊断。脑脊液中的寡克隆带仅在多发性硬化症和临床孤立综合征患者中发现,14份可用的磁共振图像中有13份显示明显异常。
冰岛获得性脱髓鞘综合征和多发性硬化症的年发病率为每100,000名儿童中有1.15例。从临床孤立综合征进展为多发性硬化症的风险很高。没有女性优势。